Abstract
The low level of effectiveness of current therapies against proliferative prostate lesions may be related to modulation of steroid hormone receptors in the mechanisms of tissue repair, angiogenesis and reactive oxygen species (ROS). In many cancers, the interaction of steroid hormone receptors with the ROS increases primary lesions triggering the rapid progression and increasing the malig…